Is There a Relationship Between Olfactory Dysfunction and Decreased Thromboembolic Events After the First Wave of the COVID-19 Pandemic?
作者信息
Akşit Ercan, Köder Ahmet
机构信息
Department of Cardiology, Çanakkale Onsekiz Mart University, Faculty of Medicine, Çanakkale, Turkey
Department of Otorhinolaryngology, Trakya University, Faculty of Medicine, Edirne, Turkey
出版信息
Balkan Med J. 2023 May 8;40(3):228-228. doi: 10.4274/balkanmedj.galenos.2023.2023-3-15. Epub 2023 Mar 24.
Abstract
摘要
相似文献
1
Is There a Relationship Between Olfactory Dysfunction and Decreased Thromboembolic Events After the First Wave of the COVID-19 Pandemic?在新冠疫情第一波流行后，嗅觉功能障碍与血栓栓塞事件减少之间是否存在关联？
Balkan Med J. 2023 May 8;40(3):228-228. doi: 10.4274/balkanmedj.galenos.2023.2023-3-15. Epub 2023 Mar 24.
2
The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom.
Rhinology. 2023 Feb 1;61(1):93-96. doi: 10.4193/Rhin22.232.
3
The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.重视 COVID-19 大流行期间及临床实践中的嗅觉功能障碍
J Allergy Clin Immunol Pract. 2021 Jan;9(1):7-12. doi: 10.1016/j.jaip.2020.10.036. Epub 2020 Oct 28.
4
Olfactory Dysfunction in COVID-19: Diagnosis and Management.新冠病毒感染中的嗅觉功能障碍：诊断与管理
JAMA. 2020 Jun 23;323(24):2512-2514. doi: 10.1001/jama.2020.8391.
5
Incomplete and late recovery of sudden olfactory dysfunction in COVID-19.在 COVID-19 中，突发性嗅觉功能障碍的恢复不完全且延迟。
Braz J Otorhinolaryngol. 2020 Jul-Aug;86(4):490-496. doi: 10.1016/j.bjorl.2020.05.001. Epub 2020 May 25.
6
[Olfactory dysfunction in COVID-19, a review of the evidence and implications for pandemic management].[新型冠状病毒肺炎中的嗅觉功能障碍：证据综述及其对大流行管理的意义]
Acta Otorrinolaringol Esp (Engl Ed). 2020 Nov-Dec;71(6):379-385. doi: 10.1016/j.otorri.2020.04.003. Epub 2020 May 11.
7
Younger adults with mild-to-moderate COVID-19 exhibited more prevalent olfactory dysfunction in Taiwan.台湾地区轻度至中度 COVID-19 的年轻患者嗅觉功能障碍更为普遍。
J Microbiol Immunol Infect. 2021 Oct;54(5):794-800. doi: 10.1016/j.jmii.2021.01.006. Epub 2021 Feb 8.
8
Olfactory disorder in patients infected with SARS-CoV-2.感染 SARS-CoV-2 患者的嗅觉障碍。
J Microbiol Immunol Infect. 2021 Oct;54(5):992-996. doi: 10.1016/j.jmii.2020.08.010. Epub 2020 Aug 20.
9
[Loss of smell, a preliminary indicator of COVID-19].[嗅觉丧失，新冠病毒病的一个初步指标]
Rev Med Inst Mex Seguro Soc. 2021 Feb 2;59(1):4-6. doi: 10.24875/RMIMSS.M21000046.
10
[Parosmia and phantosmia: clinical update].[嗅觉倒错与嗅觉幻觉：临床进展]
Rev Med Suisse. 2022 Oct 5;18(798):1837-1842. doi: 10.53738/REVMED.2022.18.798.1837.
本文引用的文献
1
Premature Myocardial Infarction: A Rising Threat.早发性心肌梗死：日益严峻的威胁。
Balkan Med J. 2022 Mar 14;39(2):83-95. doi: 10.4274/balkanmedj.galenos.2022-2-19.
2
The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste.UGT2A1/UGT2A2 基因座与 COVID-19 相关的嗅觉或味觉丧失有关。
Nat Genet. 2022 Feb;54(2):121-124. doi: 10.1038/s41588-021-00986-w. Epub 2022 Jan 17.
3
Cardiac inflammation and microvascular procoagulant changes are decreased in second wave compared to first wave deceased COVID-19 patients.与第一波新冠病毒（COVID-19）患者相比，第二波患者的心脏炎症和微血管促凝变化减少。
Int J Cardiol. 2022 Feb 15;349:157-165. doi: 10.1016/j.ijcard.2021.11.079. Epub 2021 Dec 3.
4
Which quantitative test can predict cardiocerebral syndrome in patients with heart failure?
Int J Cardiol. 2020 Nov 15;319:118. doi: 10.1016/j.ijcard.2020.05.002. Epub 2020 Jun 4.
5
Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction.替格瑞洛可成为治疗重症新冠肺炎合并心肌梗死患者的重要药物。
Balkan Med J. 2020 Jun 1;37(4):233-233. doi: 10.4274/balkanmedj.galenos.2020.2020.4.100. Epub 2020 Apr 24.
6
Asymptomatic Patients with Novel Coronavirus Disease (COVID-19).新型冠状病毒肺炎（COVID-19）无症状患者
Balkan Med J. 2020 Jun 1;37(4):229-230. doi: 10.4274/balkanmedj.galenos.2020.2020.4.20. Epub 2020 Apr 13.
7
Olfactory Dysfunction in Patients with Ischemic Heart Failure.缺血性心力衰竭患者的嗅觉功能障碍
Acta Cardiol Sin. 2020 Mar;36(2):133-139. doi: 10.6515/ACS.202003_36(2).20190812B.
8
Study of the Association of PEAR1, P2Y12, and UGT2A1 Polymorphisms with Platelet Reactivity in Response to Dual Antiplatelet Therapy in Chinese Patients.中国患者中PEAR1、P2Y12和UGT2A1基因多态性与双联抗血小板治疗反应中血小板反应性的相关性研究。
Cardiology. 2018;140(1):21-29. doi: 10.1159/000488101. Epub 2018 Apr 10.
Zotero 插件